![]() |
|
|
Vol. 29, Issue 8, 1096-1101, August 2001
Laboratory of Toxicokinetics and Metabolism, Department of
Industrial Hygiene and Toxicology, Finnish Institute of Occupational
Health, Helsinki, Finland (L.L., J.M., E.E.); Viikki Drug Discovery
Technology Center, Department of Pharmacy, University of Helsinki,
Finland (L.L., T.F., J.T.); and Department of Pharmacology and
Toxicology, University of Oulu, Oulu, Finland (P.T.)
Human UDP-glucuronosyltransferases (UGT, EC 2.4.1.17) involved in
the biotransformation of pyrene were investigated by a sensitive
fluorometric high-performance liquid chromatography (HPLC)method
developed for determining activities toward 1-hydroxypyrene. The
endpoint metabolite of pyrene, 1-pyrenylglucuronide, is a well-known
urinary biomarker for the assessment of human exposure to polycyclic
aromatic hydrocarbons. 1-Pyrenylglucuronide was synthesized using rat
liver microsomes as biocatalyst. The yield was satisfactory, 22%.
1-Pyrenylglucuronide, identified by 1H NMR and by
electrospray mass spectrometry, was used for method validation and
calibration. The HPLC assay was very sensitive with a quantitation
limit of 3 pg (8 fmol) for 1-pyrenylglucuronide. The assay was precise,
showing a relative standard deviation of 5% or less at 0.1 to 300 µM
1-hydroxypyrene. Only 2 µg of microsomal protein was required for the
assay in human liver. The glucuronidation of 1-hydroxypyrene was
catalyzed at high rates in microsomes from pooled or three individual
liver samples, showing comparable apparent Km values. The formation of
1-pyrenylglucuronide was catalyzed by recombinant human UGT1A6, UGT1A7,
and UGT1A9, the Km values being 45, 12, and
1 µM, respectively. The apparent Km values
in human liver microsomes, ranging from 6.9 to 8.6 µM, agreed well with these results. The method provides a sensitive tool for measuring extremely low UGT activities and a specific means for assessing interindividual differences in 1-hydroxypyrene-metabolizing UGT activities in human liver and other tissues.
This article has been cited by other articles:
![]() |
B. J. Dean, S. Chang, M. V. S. Elipe, Y.-Q. Xia, M. Braun, E. Soli, Y. Zhao, R. B. Franklin, and B. Karanam Metabolism of MK-0524, a Prostaglandin D2 Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans Drug Metab. Dispos., February 1, 2007; 35(2): 283 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Luukkanen, J. Taskinen, M. Kurkela, R. Kostiainen, J. Hirvonen, and M. Finel KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., July 1, 2005; 33(7): 1017 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Elovaara, J. Mikkola, L. Luukkanen, L. Antonio, S. Fournel-Gigleux, B. Burchell, J. Magdalou, and J. Taskinen ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES Drug Metab. Dispos., December 1, 2004; 32(12): 1426 - 1433. [Abstract] [Full Text] [PDF] |
||||